“A perfect operation can still be compromised if travel plans are prioritized over medical advice or if symptoms such as ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...

Cohort 3 demonstrates earlier and deeper responses compared to cohorts 1-2. All three cohorts show separation from placebo ...

IOF believes that innovation is the cornerstone of the future of orthodontics. Its mission is to foster the emergence and ...

Now in its fourth year, the FSR Global Virtual Sarcoidosis Summit is the world’s largest online sarcoidosis event, bringing together patients, caregivers, clinicians, and researchers for two days of ...

The 2024 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Praxis, or following a bona fide period of non-employment, as an ...

Armentum Partners served as financial advisor to NeuroPace on the transaction. Additional detail regarding the foregoing financing is set forth in NeuroPace’s Current Report on Form 8-K, filed today ...

Fireside Chat Details: Date: Wednesday, June 11, 2025 Time: 3:15pm EDT Webcast: https://cc.webcasts.com/gold006/060925a_js/?entity=165_UH4O74B A replay of the event will be available for 90 days and ...

Mr. Scorsis has over 25 years of experience leading companies in highly regulated industries to rapid growth, including alcohol, energy drinks, and Biotech. From October 2015 to July 2017, Mr. Scorsis ...

To access the live webcast or subsequent archived recording of the Goldman Sachs fireside chat, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.

Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, announced today that members of its senior ...

Launch of a capital increase with preferential subscription rights for nearly 5 million euros Issuance of new shares for an initial total amount of around €5.0 million, with shareholders maintaining ...